AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 102 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,231,000 | +70.9% | 122,812 | -17.1% | 0.03% | +28.6% |
| Q2 2020 | $2,475,000 | +2033.6% | 148,113 | +1734.7% | 0.02% | +2000.0% |
| Q1 2020 | $116,000 | -42.9% | 8,073 | +33.0% | 0.00% | -50.0% |
| Q4 2019 | $203,000 | -16.5% | 6,072 | -47.8% | 0.00% | 0.0% |
| Q3 2019 | $243,000 | -58.3% | 11,627 | -55.4% | 0.00% | -60.0% |
| Q1 2019 | $583,000 | -75.2% | 26,071 | -73.4% | 0.01% | -76.2% |
| Q4 2018 | $2,347,000 | +1023.0% | 98,138 | +1064.2% | 0.02% | +950.0% |
| Q3 2017 | $209,000 | +86.6% | 8,430 | +54.7% | 0.00% | +100.0% |
| Q2 2017 | $112,000 | +3.7% | 5,451 | +10.1% | 0.00% | 0.0% |
| Q1 2017 | $108,000 | -68.2% | 4,952 | -70.2% | 0.00% | -66.7% |
| Q4 2016 | $340,000 | +155.6% | 16,636 | +87.4% | 0.00% | +200.0% |
| Q3 2016 | $133,000 | – | 8,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 1,240,000 | $25,966,000 | 57.34% |
| Foresite Capital Management II, LLC | 2,605,499 | $54,559,000 | 11.53% |
| Foresite Capital Management III, LLC | 611,893 | $12,813,000 | 4.89% |
| Palo Alto Investors LP | 3,471,740 | $72,698,000 | 4.84% |
| SANDERS MORRIS HARRIS LLC | 486,906 | $10,196,000 | 2.47% |
| Eventide Asset Management | 3,084,000 | $64,579,000 | 2.13% |
| Sofinnova Investments, Inc. | 346,770 | $7,261,000 | 0.66% |
| EMERALD ADVISERS, LLC | 610,511 | $12,784,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 752,358 | $15,754,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 587,464 | $12,301,000 | 0.54% |